P190BCR-ABL1 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature

P190BCR-ABL1 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature

T-acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) is rare and aggressive leukemia. Philadelphia chromosome positive (Ph+) is the most common cytogenetic abnormality in chronic myeloid leukemia (CML) and B-acute lymphoblastic leukemia (B-ALL). Ph+ T-ALL is exceeding rare and has a the...

Full description

Bibliographic Details
Main Authors:	Samah Kohla, Sarah EL Kourashy, Zafar Nawaz, Reda Youssef, Ahmad Al-Sabbagh, Feryal A. Ibrahim
Format:	Article
Language:	English
Published:	Karger Publishers 2021-07-01
Series:	Case Reports in Oncology
Subjects:	de novo t-all p190bcr-abl1 positive acute leukemia t-cell-acute lymphoblastic leukemia philadelphia positive acute leukemia acute leukemia t-blastic phase of cml
Online Access:	https://www.karger.com/Article/FullText/516270

Similar Items

Diagnostic challenges of de novo acute leukemia with positive BCR-ABL1 fusion: Case report and review of literature
by: Abdulrahman Hamdan Almaeen
Published: (2019-01-01)

Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABL
by: Run Qin, et al.
Published: (2023-01-01)

Association of HLA antigens and BCR-ABL transcripts in leukemia patients with the Philadelphia chromosome
by: Daiana Landenberger de Carvalho, et al.
Published: (2012-01-01)

In <i>BCR-ABL1</i> Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
by: Elisa Buzzatti, et al.
Published: (2022-03-01)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report
by: Shuang Fu, et al.
Published: (2023-06-01)

Frequency of p190 and p210 BCR-ABL rearrangements and survival in Brazilian adult patients with acute lymphoblastic leukemia
by: Ilana de França Azevedo, et al.
Published: (2014-10-01)

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia: A Single-Institution Experience in Limited-Resource Setting
by: Rudresha Haleshappa Antapura, et al.
Published: (2023-04-01)

Successful Preservation of Native BCR::ABL1 in Chronic Myeloid Leukemia Primary Leukocytes Reveals a Reduced Kinase Activity
by: Christian Boni, et al.
Published: (2022-06-01)

Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era
by: Ting Shi, et al.
Published: (2020-11-01)

High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR‐ABL1‐like acute lymphoblastic leukemia
by: Jae Wook Lee, et al.
Published: (2020-07-01)

A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens
by: Zhen-Yu Xiong, et al.
Published: (2024-12-01)

Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
by: Kazuki Tanimura, et al.
Published: (2021-02-01)

A rare case of Philadelphia-positive (P210BCR-ABL1) T-cell acute lymphoblastic leukemia/lymphoma associated with minimal residual disease persistence after intensive chemotherapeutic approaches
by: Shruti Shah, et al.
Published: (2024-01-01)

A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review
by: Monica Piedimonte, et al.
Published: (2019-01-01)

Dasatinib: ten years of clinical practice worldwide
by: K. M. Abdulkadyrov, et al.
Published: (2016-03-01)

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen
by: Ruiqi Chen, et al.
Published: (2020-12-01)

Amplification of the BCR: : ABL1 Fusion Gene: A Rare Phenomenon in B-cell Acute Lymphoblastic Leukemia
by: Debadrita Ray, et al.
Published: (2023-08-01)

Acute lymphoblastic leukemia with e1A3 BCR-ABL fusion protein: report of 2 cases and literature review
by: CHEN Siyu, et al.
Published: (2021-10-01)

De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome
by: Min Xiao, et al.
Published: (2011-11-01)

P190BCR-ABL Chronic Myeloid Leukemia Following a Course of S-1 Plus Oxaliplatin Therapy For Advanced Gastric Adenocarcinoma
by: Hua Wang, et al.
Published: (2017-01-01)

Frequency of the minor BCR-ABL (e1;a2) transcript oncogene in a Mexican population with adult acute lymphoblastic leukaemia
by: I. Olarte-Carrillo, et al.
Published: (2015-07-01)

A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges
by: Nada Naiyer, MD, et al.
Published: (2022-01-01)

Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil
by: Fernando Callera, et al.
Published: (2015-02-01)

Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
by: Vidhi Malik, et al.
Published: (2022-01-01)

Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)
by: Rabia Khalid, et al.
Published: (2023-12-01)

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
by: Shohei Mizuno, et al.
Published: (2024-04-01)

Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
by: Yadvinder Singh, et al.
Published: (2013-11-01)

Ponatinib: A drug review
by: Hasmukh Jain, et al.
Published: (2019-01-01)

Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023-04-01)

Cost-effectiveness analysis of dasatinib versus imatinib in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia patients in China
by: Wang Cao, et al.
Published: (2022-12-01)

Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years′ experience from a tertiary care center in India
by: Madhav Danthala, et al.
Published: (2016-01-01)

Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation
by: Wellington F. Silva, et al.
Published: (2022-12-01)

Coexistence of P190 BCR/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report
by: najmaldin saki, et al.
Published: (2016-01-01)

Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts
by: Samuel J. Holzmayer, et al.
Published: (2024-03-01)

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy
by: Huang X, et al.
Published: (2019-06-01)

Cost-effectiveness analysis of imatinib versus dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia when combined with conventional chemotherapy in China
by: Min Chen, et al.
Published: (2023-06-01)

Cardiotoxicity of Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients
by: Adriatik Berisha, et al.
Published: (2023-02-01)

Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
by: Hong Hoe Koo
Published: (2011-03-01)

Experiencia del Grupo Español de Trasplante Hematopoyético (GETMON-GETH) en el trasplante alogénico de progenitores hematopoyéticos en leucemia aguda linfoblástica Philadelphia
by: Víctor Galán Gómez, et al.
Published: (2022-04-01)